Skip to content

Actions: mrc-ide/malariasimulation

Continuous benchmarking

Actions

Loading...
Loading

Show workflow options

Create status badge

Loading
78 workflow runs
78 workflow runs

Filter by Event

Filter by Status

Filter by Branch

Filter by Actor

Add R21 PEV profiles
Continuous benchmarking #53: Issue comment #333 (comment) created by giovannic
September 10, 2024 18:10 4s
September 10, 2024 18:10 4s
Add R21 PEV profiles
Continuous benchmarking #52: Issue comment #333 (comment) created by pwinskill
September 10, 2024 15:59 4s
September 10, 2024 15:59 4s
Add R21 PEV profiles
Continuous benchmarking #51: Issue comment #333 (comment) created by lmhaile
September 10, 2024 13:58 4s
September 10, 2024 13:58 4s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #50: Issue comment #334 (comment) created by RJSheppard
September 10, 2024 11:53 4s
September 10, 2024 11:53 4s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #49: Issue comment #334 (comment) edited by RJSheppard
September 10, 2024 11:53 4s
September 10, 2024 11:53 4s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #48: Issue comment #334 (comment) edited by RJSheppard
September 10, 2024 11:53 3s
September 10, 2024 11:53 3s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #47: Issue comment #334 (comment) edited by RJSheppard
September 10, 2024 11:52 5s
September 10, 2024 11:52 5s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #46: Issue comment #334 (comment) edited by RJSheppard
September 10, 2024 11:45 4s
September 10, 2024 11:45 4s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #45: Issue comment #334 (comment) edited by RJSheppard
September 10, 2024 11:45 4s
September 10, 2024 11:45 4s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #44: Issue comment #334 (comment) edited by RJSheppard
September 10, 2024 11:44 4s
September 10, 2024 11:44 4s
recovery_rates variable has been renamed as (disease) progression_rates.
Continuous benchmarking #43: Issue comment #334 (comment) created by RJSheppard
September 10, 2024 11:43 4s
September 10, 2024 11:43 4s
Competing hazards recovery infection resolution
Continuous benchmarking #42: Issue comment #300 (comment) created by plietar
August 13, 2024 15:25 4s
August 13, 2024 15:25 4s
Competing hazards recovery infection resolution
Continuous benchmarking #41: Issue comment #300 (comment) created by giovannic
August 13, 2024 14:15 4s
August 13, 2024 14:15 4s
Vivax competing hazards main parameters
Continuous benchmarking #40: Issue comment #315 (comment) created by RJSheppard
August 1, 2024 10:48 4s
August 1, 2024 10:48 4s
Assign names to all processes.
Continuous benchmarking #39: Issue comment #325 (comment) created by plietar
July 22, 2024 12:44 1h 6m 14s
July 22, 2024 12:44 1h 6m 14s
Assign names to all processes.
Continuous benchmarking #38: Issue comment #325 (comment) created by giovannic
July 15, 2024 09:03 1h 2m 16s
July 15, 2024 09:03 1h 2m 16s
Competing hazards recovery infection resolution
Continuous benchmarking #37: Issue comment #300 (comment) created by plietar
July 10, 2024 15:19 1h 3m 39s
July 10, 2024 15:19 1h 3m 39s
Competing hazards recovery infection resolution
Continuous benchmarking #36: Issue comment #300 (comment) created by plietar
July 10, 2024 14:08 1h 5m 13s
July 10, 2024 14:08 1h 5m 13s
Competing hazards recovery infection resolution
Continuous benchmarking #35: Issue comment #300 (comment) created by plietar
July 10, 2024 13:49 19m 59s
July 10, 2024 13:49 19m 59s
Vivax competing hazards main parameters
Continuous benchmarking #34: Issue comment #315 (comment) created by RJSheppard
July 9, 2024 16:38 5s
July 9, 2024 16:38 5s
Remove severe immunity for P.v
Continuous benchmarking #33: Issue comment #319 (comment) created by pwinskill
July 8, 2024 15:12 5m 29s
July 8, 2024 15:12 5m 29s
p.v sub-patent duration is immunity dependent.
Continuous benchmarking #32: Issue comment #318 (comment) created by pwinskill
July 8, 2024 14:28 4m 49s
July 8, 2024 14:28 4m 49s
Remove blood immunity from p.v model
Continuous benchmarking #31: Issue comment #317 (comment) created by pwinskill
July 8, 2024 14:27 5m 4s
July 8, 2024 14:27 5m 4s
p.v constant asymptomatic infectivity
Continuous benchmarking #30: Issue comment #316 (comment) created by pwinskill
July 8, 2024 14:27 5m 11s
July 8, 2024 14:27 5m 11s
Vivax competing hazards main parameters
Continuous benchmarking #29: Issue comment #315 (comment) created by pwinskill
July 8, 2024 14:27 5m 49s
July 8, 2024 14:27 5m 49s